FIELD: medicine, biotechnology, pharmaceutical industry.
SUBSTANCE: method involves increasing part of the most active conformation of a glycosylated recombinant protein secreted by mammalian cell by its contact with a reagent for coupled oxidation-reduction. The proposed promotion method of the most active conformation of protein is used in a method for preparing a glycosylated recombinant protein in its the most active conformation. Configuration isomer of protein prepared by the indicated method for preparing a glycosylated recombinant protein in it's the most active conformation used in a method for preparing the protein composition for its administration to user and/or a patient or for consumption by user and/or patient. Using of the proposed invention provides enhancing activity of glycosylated protein prepared by a method of recombinant DNAs using a mammalian cell.
EFFECT: improved preparing method, valuable properties of protein.
27 cl, 9 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF EXTRACTING REFOLDED RECOMBINANT PROTEIN FROM PROKARYOTIC CELL CULTURE (VERSIONS) | 2007 |
|
RU2439076C2 |
RECOMBINANT PRODUCTION OF HEPARIN BINDING PROTEINS | 2006 |
|
RU2385877C1 |
FUSION PROTEIN PURIFICATION METHOD | 2015 |
|
RU2698654C2 |
METHOD FOR OBTAINING TNFR-Fc FUSION PROTEIN WITH ASSIGNED CONTENT OF IMPURITIES | 2015 |
|
RU2670166C1 |
SINGLE-STRANDED CD40 RECEPTOR AGONIST PROTEINS | 2016 |
|
RU2745801C2 |
STABLE PHARMACEUTICAL COMPOSITION OF TNFR: FC FUSION PROTEIN | 2013 |
|
RU2664691C2 |
LIQUID COMPOSITION OF POLYPEPTIDES CONTAINING FC DOMAIN OF IMMUNOGLOBULIN | 2011 |
|
RU2600847C2 |
PRODUCTION OF BIOLOGICALLY ACTIVE PROTEINS | 2007 |
|
RU2441911C2 |
QUANTITATIVE ESTIMATION OF MISFOLDED TNFR2:Fc | 2015 |
|
RU2698671C2 |
HETEROMULTIMERIC PROTEINS PRODUCTION | 2011 |
|
RU2624027C2 |
Authors
Dates
2008-02-10—Published
2002-02-22—Filed